For its third fiscal quarter (ending September 30), Cytokinetics Inc (NASDAQ: CYTK) has reported E.P.S. of $-1.35 compared to $-1.52 a year ago. This result fell short of the consensus estimate of $-0.78 by $-0.57. […]
For its third fiscal quarter (ending September 30), Beacon Roofing Supply Inc (NASDAQ: BECN) has reported a -309% decline in E.P.S. from $1.99 a year ago to $-4.16 in the current quarter. This performance was […]
VIRTU FINANCIAL INC (NASDAQ: VIRT) has reported earnings for its third fiscal quarter (ending September 30) of $0.63 versus $0.38 for the same period a year ago — an increase of 66%. This result exceeded […]
Booking Holdings Inc (NASDAQ: BKNG) has reported E.P.S. of $70.62 for its third fiscal quarter (ending September 30) versus $42.10 for the same period a year ago — an increase of 68%. This performance was […]
Quanta Services Inc. (NYSE: PWR) has reported earnings for its third fiscal quarter (ending September 30) of $1.88 versus $1.09 for the same period a year ago — an increase of 72%. However, this performance […]
Teekay Corp (NYSE: TK) has reported E.P.S. of $0.28 for its third fiscal quarter (ending September 30) versus $0.32 for the same period a year ago — a decline of -12%. For the latest four […]
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) has reported a loss for its third fiscal quarter (ending September 30) of $-0.19 versus a loss $-0.23 for the same period a year ago. This result was in line […]
For its third fiscal quarter (ending September 30), Innodata Inc (NASDAQ: INOD) has reported E.P.S. of $0.01 compared to $-0.12 a year ago. E.P.S. were $-0.16 for the latest four quarters through September 30 versus […]
Stryker Corp (NYSE: SYK) has reported E.P.S. of $1.82 for its third fiscal quarter (ending September 30) versus $2.16 for the same period a year ago — a decline of -16%. Relative to the consensus […]
Standex International Corp (NYSE: SXI) has reported E.P.S. of $1.61 for its first fiscal quarter (ending September 30) versus $1.55 for the same period a year ago — an increase of 4%. Relative to the […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research